Ticker Details
CareDx, Inc. CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.
IPO Date:	July 17, 2014
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$1.42B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.68 | 3.34%
Avg Daily Range (30 D):	$0.68 | 2.74%
Avg Daily Range (90 D):	$0.61 | 2.94%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	3,571
Avg Institutional Trade:	$2.35M
Avg Institutional Trade (30 D):	$3.82M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.84M
Avg Closing Trade (30 D):	$4.95M
Avg Closing Trade (90 D):	$3.24M
Avg Closing Volume:	119.01K

News

Apr 16, 2026 @ 6:37 PM CareDx Sharpens Focus On Core Testing Services Source: Vandana Singh

Feb 1, 2026 @ 8:16 AM CareDx's CEO Conducts Multiple Sale of Shares Towa... Source: Adé Hennis

May 22, 2025 @ 12:48 AM Johnson Fistel has Commenced an Investigation on B... Source: N/A

Sep 24, 2024 @ 6:42 PM ALERTA PARA LOS ACCIONISTAS: Morris Kandinov inves... Source: N/A

Sep 24, 2024 @ 10:00 AM SHAREHOLDER ALERT: Morris Kandinov Investigating C... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.05	$-.08	$-.4
Diluted EPS	$.05	$-.08	$-.4
Revenue	$117.7M	$108.39M	$379.81M
Gross Profit
Net Income / Loss	$2.81M	$-4.11M	$-21.35M
Operating Income / Loss	$1.2M	$-6.04M	$-30.78M
Cost of Revenue
Net Cash Flow	$12.48M	$-26.01M	$-49.2M
PE Ratio